Literature DB >> 32551168

Protective effects of hesperetin on lipopolysaccharide-induced acute lung injury in a rat model.

Serkan Kaya1, Sinem Albayrak Kaya2, Elif Polat3, Zeynep Fidanol Erboğa3, Yasin Duran4, Fatin Rüştü Polat4, Hamza Malik Okuyan5, İhsan Karaboğa6.   

Abstract

BACKGROUND: In this experimental study, we aimed to investigate the effects of hesperetin, a natural flavonoid, on a lipopolysaccharideinduced acute lung injury model in rats.
METHODS: Between March 2019 and May 2019, a total of 18 adult male Wistar albino rats, weighing approximately 250 to 300 g, were randomly divided into three groups as control, lipopolysaccharide, and lipopolysaccharide + hesperetin groups (n=6 in each group). The wet/dry weight ratio of lung tissue was determined. Histopathological changes were examined using light and scanning electron microscopy. Pulmonary nuclear factor-kappa beta, inducible nitric oxide synthase, and alpha-smooth muscle antigen activity were determined with indirect immunohistochemical methods. Pulmonary apoptosis was detected with the terminal deoxynucleotidyl transferase dUTP nick-end labeling method. Tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, and interleukin-10 concentrations were measured with enzyme-linked immunosorbent assay.
RESULTS: Treatment with hesperetin significantly improved the architecture of lung tissue and reduced the wet/dry weight ratio, nuclear factor-kappa beta, inducible nitric oxide synthase, and alphasmooth muscle antigen expression, pulmonary apoptosis, and levels of proinflammatory cytokines.
CONCLUSION: Our study results suggest that hesperetin has a potent protective effect against lipopolysaccharide-induced acute lung injury in rats via suppression of the proinflammatory cytokine cascade, nuclear factor-kappa beta, signaling pathway activation, and apoptosis.
Copyright © 2020, Turkish Society of Cardiovascular Surgery.

Entities:  

Keywords:  Acute lung injury; inducible nitric oxide synthase; lipopolysaccharide; nuclear factor-kappa beta; pulmonary apoptosis; tumor necrosis factor-alpha

Year:  2020        PMID: 32551168      PMCID: PMC7298383          DOI: 10.5606/tgkdc.dergisi.2020.18816

Source DB:  PubMed          Journal:  Turk Gogus Kalp Damar Cerrahisi Derg        ISSN: 1301-5680            Impact factor:   0.332


  38 in total

Review 1.  [Nuclear factor-ΚB pathway and acute lung injury in hemorrhagic shock].

Authors:  Lina Zhang; Ziyong Yue
Journal:  Zhonghua Wei Zhong Bing Ji Jiu Yi Xue       Date:  2014-08

2.  H2S Attenuates LPS-Induced Acute Lung Injury by Reducing Oxidative/Nitrative Stress and Inflammation.

Authors:  Hong-Xia Zhang; Shu-Juan Liu; Xiao-Lu Tang; Guo-Li Duan; Xin Ni; Xiao-Yan Zhu; Yu-Jian Liu; Chang-Nan Wang
Journal:  Cell Physiol Biochem       Date:  2016-12-23

3.  Scutellarin protects against lipopolysaccharide-induced acute lung injury via inhibition of NF-kappaB activation in mice.

Authors:  Zheng-Huai Tan; Ling-Hong Yu; Huai-Ling Wei; Geng-Tao Liu
Journal:  J Asian Nat Prod Res       Date:  2010-03       Impact factor: 1.569

Review 4.  Acute lung injury in thoracic surgery.

Authors:  Giorgio Della Rocca; Cecilia Coccia
Journal:  Curr Opin Anaesthesiol       Date:  2013-02       Impact factor: 2.706

5.  Preventive effects of valnemulin on lipopolysaccharide-induced acute lung injury in mice.

Authors:  Zhibao Chen; Xuemei Zhang; Xiao Chu; Xiaozhe Zhang; Keji Song; Youshuai Jiang; Lu Yu; Xuming Deng
Journal:  Inflammation       Date:  2010-10       Impact factor: 4.092

6.  Roles of iNOS and nNOS in sepsis-induced pulmonary apoptosis.

Authors:  Jill C Rudkowski; Esther Barreiro; Rania Harfouche; Peter Goldberg; Osama Kishta; Pedro D'Orleans-Juste; Julie Labonte; Olivier Lesur; Sabah N A Hussain
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-12-05       Impact factor: 5.464

7.  Remifentanil attenuates lipopolysaccharide-induced acute lung injury by downregulating the NF-κB signaling pathway.

Authors:  Ying Zhang; Zhaohui Du; Qing Zhou; Yanlin Wang; Jianguo Li
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

8.  The therapeutic effects of traditional Chinese medicine Fusu agent in LPS-induced acute lung injury model rats.

Authors:  Peiyang Gao; Ziyi Zhao; Chuantao Zhang; Chunxia Wang; Kunlan Long; Liuxue Guo; Baixue Li
Journal:  Drug Des Devel Ther       Date:  2018-11-13       Impact factor: 4.162

9.  Galantamine protects against lipopolysaccharide-induced acute lung injury in rats.

Authors:  G Li; C L Zhou; Q S Zhou; H D Zou
Journal:  Braz J Med Biol Res       Date:  2015-12-04       Impact factor: 2.590

10.  Anti-Inflammatory and Anti-Oxidant Activity of Portulaca oleracea Extract on LPS-Induced Rat Lung Injury.

Authors:  Vafa Baradaran Rahimi; Hassan Rakhshandeh; Federica Raucci; Benedetta Buono; Reza Shirazinia; Alireza Samzadeh Kermani; Francesco Maione; Nicola Mascolo; Vahid Reza Askari
Journal:  Molecules       Date:  2019-01-01       Impact factor: 4.411

View more
  2 in total

1.  Royal jelly attenuates gastric mucosal injury in a rat ethanol-induced gastric injury model.

Authors:  Yasin Duran; İhsan Karaboğa; Fatin Rüştü Polat; Elif Polat; Zeynep Fidanol Erboğa; Mehmet Akif Ovalı; Rahime Özlem Öztopuz; Aliye Çelikkol; Ahsen Yılmaz
Journal:  Mol Biol Rep       Date:  2020-11-01       Impact factor: 2.316

Review 2.  Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS-CoV-2.

Authors:  Abhishek Gour; Diksha Manhas; Swarnendu Bag; Bapi Gorain; Utpal Nandi
Journal:  Phytother Res       Date:  2021-03-30       Impact factor: 6.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.